We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Scientists Create Bioartificial Bone in Lab

By Biotechdaily staff writers
Posted on 18 Jul 2002
In what they describe as breakthrough research, Israeli scientists have shown that patients in need of an organ transplant may soon be able to provide a tissue sample and then wait a week or two until it has been used to custom-build the necessary organ.

Dr. More...
Gadi Pelled, working under the guidance of Prof. Dan Gazit at Hebrew University (Jerusalem, Israel; www.huji.ac.il), has managed to grow and then combine cells from blood vessels and genetically engineered adult stem cells to create three-dimensional bioartificial bone in the laboratory. Although Dr. Pelled has only conducted research on bone thus far, he says the method can be applied to any tissue that has blood vessels. One of the major difficulties in creating bioartificial organs, he notes, is creating a network of blood vessels in the organ that can connect to those in the body.

The technology has been exclusively licensed to SBT, a startup company founded by the Yissum Research Development Company of Hebrew University and Prof. Gazit. SBT's mission is to engineer skeletal tissue and vascular tissues, including bone, cartilage, tendons, ligaments, and blood vessels. SBT has experience in this field, having developed proprietary biologic technology targeted at the use of ex-vivo tissue engineering for the generation of tissues such as these and having also developed methods of treating diabetes, heart disease, and stroke. The company has also developed an ex-vivo three-dimensional system for screening drugs.

Dr. Pelled received a Kaye Award for his research. The Kaye Innovation Awards at Hebrew University are designed to encourage faculty and students to develop innovative methods and inventions with good commercial potential that will benefit the university and society.

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.